CTBO

Cantabio Pharmaceuticals (CE) (CTBO)

Cantabio Pharmaceuticals Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:CTBO

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2019/06/22	05 : 12	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/06/22	05 : 09	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/06/22	05 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/06/18	03 : 20	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/05/25	05 : 51	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/05/25	05 : 36	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/05/16	06 : 43	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/05/16	06 : 39	Edgar (US Regulatory)	Information Statements (revised) (prer14c)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/05/09	02 : 05	Edgar (US Regulatory)	Information Statements (revised) (prer14c)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/05/09	01 : 55	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/04/11	04 : 14	Edgar (US Regulatory)	Statement of Ownership: Private Transaction (sc 13e3)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/03/23	03 : 25	Edgar (US Regulatory)	Proxy Statement - Other Information (preliminary) (pre 14c)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2019/03/22	04 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/12/15	04 : 27	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/11/14	02 : 56	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/10/15	23 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/10/12	06 : 08	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/10/12	06 : 05	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/10/12	06 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/08/21	04 : 55	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/08/15	23 : 09	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/07/16	19 : 02	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/06/29	23 : 54	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/06/08	23 : 21	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/04/11	23 : 33	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/02/21	02 : 42	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2018/02/15	05 : 17	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2017/11/28	02 : 41	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2017/11/15	04 : 56	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
2017/08/15	04 : 22	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)